Status:
COMPLETED
Effectiveness of Patient-Controlled Intravenous Analgesia (PCIA) With Fentanyl
Lead Sponsor:
Egymedicalpedia
Collaborating Sponsors:
October 6 University
Conditions:
Total Hip Replacement
Eligibility:
All Genders
Up to 40 years
Phase:
PHASE1
Brief Summary
To enhance post-operative pain management, patient-controlled intravenous analgesia (PCIA) has been employed. The fentanyl background PCIA therapy was created to solve the limitations of IV-based PCIA...
Detailed Description
Significant efforts to enhance the treatment of postoperative pain have resulted in the formulation and implementation of pain management guidelines, as well as the introduction of acute pain services...
Eligibility Criteria
Inclusion
- \- Patients with total fracture of Hip bones
Exclusion
- History of mental or neurological complaints,
- Opioid and local anaesthetic allergies,
- Opioid tolerance,
- Smoking history,
- local infection,
- cemented total hip arthroplasty (THA), revision THA,
- preoperative DVT,
- renal failure,
- bleeding tendency due to anticoagulant therapy
Key Trial Info
Start Date :
March 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 28 2022
Estimated Enrollment :
70 Patients enrolled
Trial Details
Trial ID
NCT05429567
Start Date
March 1 2021
End Date
February 28 2022
Last Update
June 23 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
October 6 University
Giza, Cairo Governorate, Egypt